Preclinical data described upregulation of ACE2 by either ACEi or ARBs which may on one hand exert beneficial effects by suppressing inflammation and protect cells from increased sympathetic activity [18], but on the other hand raised concerns that this would result in increased risk for infection with SARS-CoV2 and a higher risk for a complicated course of the disease. This evidence concerns the gene ACE2 and infection.